|
|
| GeneID |
610
|
| Symbol |
HCN2
|
| Synonyms |
BCNG-2|BCNG2|HAC-1
|
| Description |
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| See related |
HGNC:4846|MIM:602781|Ensembl:ENSG00000099822|HPRD:07213| |
| Locus tag |
- |
| Gene type |
protein-coding |
| Map location |
19p13.3 |
|
| |
|
|
| Gene set name |
Method of gene set |
Evidence |
Info |
| Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: [schizophrenias, schizophrenia] | Click to show detail |
|
| |
| General Gene Expression (microarray) ? |
|
 |
| |
| Gene Expression in Brain Regions (new) |
|
| |
| Top co-expressed genes in Brain Regions (new) |
|
| Gene | Pearson's Correlation | Spearman's Correlation | | |
| Top 10 positively co-expressed genes |
| FAM171A1 | 0.89 | 0.88 | | |
| ULK1 | 0.87 | 0.89 | | |
| SRF | 0.85 | 0.91 | | |
| AKAP1 | 0.84 | 0.86 | | |
| MESDC1 | 0.83 | 0.84 | | |
| RAPGEF1 | 0.83 | 0.89 | | |
| WDTC1 | 0.82 | 0.88 | | |
| RUNDC1 | 0.82 | 0.86 | | |
| DAB2IP | 0.82 | 0.88 | | |
| FAM168B | 0.82 | 0.87 | | |
Top 10 negatively co-expressed genes | | AF347015.21 | -0.68 | -0.76 | | |
| AF347015.31 | -0.63 | -0.67 | | |
| MT-CO2 | -0.62 | -0.66 | | |
| C1orf54 | -0.62 | -0.74 | | |
| GNG11 | -0.60 | -0.67 | | |
| SYCP3 | -0.60 | -0.68 | | |
| AF347015.8 | -0.59 | -0.64 | | |
| HIGD1B | -0.58 | -0.65 | | |
| NOSTRIN | -0.58 | -0.63 | | |
| MYL3 | -0.57 | -0.62 | | |
|
| Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0000166 | nucleotide binding | IEA | | - |
| GO:0005515 | protein binding | IEA | | - |
| GO:0005244 | voltage-gated ion channel activity | IEA | | - |
| GO:0005249 | voltage-gated potassium channel activity | IEA | | - |
| GO:0005272 | sodium channel activity | IEA | | - |
| GO:0030552 | cAMP binding | IEA | | - |
| GO:0030955 | potassium ion binding | IEA | | - |
| GO:0031402 | sodium ion binding | IEA | | - |
| Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0007267 | cell-cell signaling | TAS | | 9630217 |
| GO:0006814 | sodium ion transport | IEA | | - |
| GO:0006812 | cation transport | TAS | | 10228147 |
| GO:0006813 | potassium ion transport | IEA | | - |
| GO:0006936 | muscle contraction | TAS | | 10228147 |
| GO:0042391 | regulation of membrane potential | IEA | | - |
| Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0016020 | membrane | IEA | | - |
| GO:0016021 | integral to membrane | IEA | | - |
| GO:0008076 | voltage-gated potassium channel complex | TAS | | 9630217 |
| |
|
|
| |
|
|
|
|
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.
|